Literature DB >> 1682660

Liver failure due to recombinant alpha interferon.

J M Durand, G Kaplanski, I Portal, C Scheiner, Y Berland, J Soubeyrand.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1682660     DOI： 10.1016/0140-6736(91)92132-l

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Fatal hepatic decompensation associated with interferon alfa. European concerted action on viral hepatitis (Eurohep).

Authors:  H L Janssen; J T Brouwer; F Nevens; J M Sanchez-Tapias; A Craxi; S Hadziyannis
Journal:  BMJ       Date:  1993-01-09

Review 2.  Clinical toxicity of the interferons.

Authors:  T Vial; J Descotes
Journal:  Drug Saf       Date:  1994-02       Impact factor: 5.606

3.  Hepatic reactions during treatment of multiple sclerosis with interferon-beta-1a: incidence and clinical significance.

Authors:  Gordon S Francis; Yves Grumser; Enrica Alteri; Alain Micaleff; Fanny O'Brien; Jonathan Alsop; Margaretha Stam Moraga; Neil Kaplowitz
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

4.  Severe acute exacerbation of chronic hepatitis B during pegylated interferon treatment and early intervention with corticosteroid.

Authors:  Qing Mao; Hui-Yan Zhang; Jian-Ping You; Xu-Qing Zhang
Journal:  Virol J       Date:  2012-07-24       Impact factor: 4.099

Review 5.  Antiviral drugs for viruses other than human immunodeficiency virus.

Authors:  Raymund R Razonable
Journal:  Mayo Clin Proc       Date:  2011-10       Impact factor: 7.616
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.